Andrew Heitman

Andrew Heitman has extensive work experience in the pharmaceutical and clinical research industry. Andrew currently holds the position of Associate Director, Clinical Pharmacology at Sage Therapeutics, where they have been employed since 2021. Prior to this role, Andrew served as the Associate Director, Clinical Operations and Development at the same company from 2022 to 2023. Before joining Sage Therapeutics, they worked at Supernus Pharmaceuticals, Inc. as a Senior Manager - Clinical Development from 2019 to 2019. From 2018 to 2019, Andrew gained experience as a Program Manager (contract) at Otsuka Pharmaceutical Companies (U.S.). Andrew also held positions at Vanda Pharmaceuticals as a Clinical Project Manager from 2015 to 2018 and as a Manager, Clinical Informatics from 2012 to 2015. Additionally, they worked as a Data Manager at Cardiocore from 2011 to 2012 and as a Data Manager/Protocol Monitor at The EMMES Corporation from 2008 to 2011. In the earlier stages of their career, Andrew worked as a Medical Data Coordinator at Lockheed Martin from 2006 to 2008, as a Research Assistant III at MedStar Research in 2005, as a Research Assistant III at Georgetown University in 2005, and as an IRTA Research Fellow at NIH/NIA/Laboratory of Genetics from 2002 to 2004.

Andrew Heitman earned a High School Diploma from the University School of Milwaukee in 1998. Andrew then went on to attend Hobart and William Smith Colleges, where they obtained a Bachelor of Science (BS) degree in Biology. After completing their undergraduate studies, Andrew pursued further education at Georgetown University, where they earned a Master of Science (MS) degree as well as a Doctor of Philosophy (PhD) degree in Pharmacology. The specific start and end years for each degree are not provided.